Christina Popp

Fraunhofer Institute for Silicate Research

Papers

Total Citations

H-Index

About

Christina Popp is a pioneering researcher at the intersection of robotics and tissue engineering, with a primary focus on developing automated platforms for biological production. Her most-cited work, "ReBiA—Robotic Enabled Biological Automation: 3D Epithelial Tissue Production" (2024, 13 citations), addresses a critical shift in regulatory science following the FDA's decision to phase out mandatory animal testing for drug approval. Popp's major contribution lies in creating robotic systems capable of fabricating complex 3D epithelial tissues, offering a scalable, animal-free alternative for pharmaceutical testing. This work directly supports the European Parliament's push for faster adoption of non-animal research methods, aligning with growing public demand for ethical science. By integrating robotics with cell biology, Popp has established a framework for high-throughput, reproducible tissue production that could transform preclinical drug development. Her research not only advances automation in biology but also provides practical solutions for regulatory transitions, making her a key figure in the movement toward more humane and efficient drug testing paradigms.